Prof. Matthew Groves from the Groningen Research Institute of Pharmacy (GRIP) is partner in a consortium that has been awarded a H2020 Marie Curie ETN grant. The grant of EUR 3.2 million is for the MepAnti project, which aims to tackle the antimicrobial resistance problem by targeting enzymes of the methylerythritol phosphate pathway.
Antimicrobial resistance is a serious global health problem and, at present, there is no inter-institutional and interdisciplinary consortium explicitly focused on the discovery and development of novel anti-infective agents. The MepAnti consortium consists of nine academic partners and seven non-academic partners. The Helmholtz Institute for Pharmaceutical Research Saarland is coordinator. The consortium aims to go beyond the state-of-the-art in the anti-infective field by tackling the attractive and underexplored enzymes from the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
Prof. Groves receives EUR 265,000 for his part in the project. He will provide structural biology and biophysical expertise, with a focus on the first and rate-limiting step catalyzed by DXS.
A consortium of businesses and knowledge institutions from the Northern Netherlands join forces on the development of smart agricultural robots. The prototypes will be ready in 2027.
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Nathalie Katsonis, Edwin Otten and Alexandra Zhernakova. Professor of Coastal Ecology Tjisse van der Heide has also received a Vici grant for research he...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information